The DOI matches its Crossref record; 69 of the 71 references it cites were found in a registry or an index.
Imaging of Peripheral Benzodiazepine Receptor Expression as Biomarkers of Detrimental versus Beneficial Glial Responses in Mouse Models of Alzheimer's and Other CNS Pathologies
Open accessAbstract
We demonstrate the significance of peripheral benzodiazepine receptor (PBR) imaging in living mouse models of Alzheimer's disease (AD) as biomarkers and functional signatures of glial activation. By radiochemically and immunohistochemically analyzing murine models of the two pathological hallmarks of AD, we found that AD-like Aβ deposition is concurrent with astrocyte-dominant PBR expression, in striking contrast with nonastroglial PBR upregulation in accumulations of AD-like phosphorylated tau. Because tau-induced massive neuronal loss was distinct from the marginal neurodegeneration associated with Aβ plaques in these models, cellular localization of PBR reflected deleterious and beneficial glial reactions to tau versus Aβ pathologies, respectively. This notion was subsequently examined in models of various non-AD neuropathologies, revealing the following reactive glial dynamics underlying differential PBR upregulation: (1) PBR(−) astrogliosis uncoupled with microgliosis or coupled with PBR(+) microgliosis associated with irreversible neuronal insults; and (2) PBR(+) astrogliosis coupled with PBR(− or ±) microgliosis associated with minimal or reversible neuronal toxicity. Intracranial transplantation of microglia also indicated that nontoxic microglia drives astroglial PBR expression. Moreover, levels of glial cell line-derived neurotrophic factor (GDNF) in astrocytes were correlated with astroglial PBR, except for increased GDNF in PBR(-) astrocytes in the model of AD-like tau pathology, thereby suggesting that PBR upregulation in astrocytes is an indicator of neurotrophic support. Together, PBR expressions in astrocytes and microglia reflect beneficial and deleterious glial reactions, respectively, in diverse neurodegenerative disorders including AD, pointing to new applications of PBR imaging for monitoring the impact of gliosis on the pathogenesis and treatment of AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Similarly, others have found that TSPO positive microglia, astrocytes and endothelium are all increased in models of Alzheimer’s-like neurodegeneration [48–51] and in postmortem human Alzheimer’s disease brains [27].”
From Pharmacological modulation of TSPO in microglia/macrophages and neurons in a chronic neurodegenerative model of prion disease (2023) · cites this paper as [48]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990
Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model
Yoshiyama, Y., Higuchi, M., Zhang, B., Huang, S.-M., Iwata, N., Saido, T. C., Maeda, J., Suhara, T., Trojanowski, J. Q., & Lee, V. M.-Y. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.010 · Cited by 2,208
Self-citationTwo amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology
Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K.-H., Mistl, C., Rothacher, S., Ledermann, B., Bürki, K., Frey, P., Paganetti, P. A., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13287 · Cited by 1,507
Self-citationDirect brain infusion of glial cell line–derived neurotrophic factor in Parkinson disease
Gill, S. S., Patel, N. K., Hotton, G. R., O'Sullivan, K., McCarter, R., Bunnage, M., Brooks, D. J., Svendsen, C. N., & Heywood, P. (2003) · Nature Medicine · doi:10.1038/nm850 · Cited by 1,290
Kordower, J. H., Emborg, M. E., Bloch, J., Ma, S. Y., Chu, Y., Leventhal, L., McBride, J. L., Chen, E., Palfi, S., Roitberg, B. Z., et al. (2000) · Science · doi:10.1126/science.290.5492.767 · Cited by 1,251
Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo
Tomac, A., Lindqvist, E., Lin, L.-F. H., Ögren, S. O., Young, D., Hoffer, B. J., & Olson, L. (1995) · Nature · doi:10.1038/373335a0 · Cited by 1,079
In-vivo measurement of activated microglia in dementia
Cagnin, A., Brooks, D. J., Kennedy, A. M., Gunn, R. N., Myers, R., Turkheimer, F. E., Jones, T., & Banati, R. B. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05625-2 · Cited by 1,054
Matsushima, G. K., & Morell, P. (2001) · Brain Pathology · doi:10.1111/j.1750-3639.2001.tb00385.x · Cited by 984
Functional recovery in parkinsonian monkeys treated with GDNF
Gash, D. M., Zhang, Z., Ovadia, A., Cass, W. A., Yi, A., Simmerman, L., Russell, D., Martin, D., Lapchak, P. A., Collins, F., et al. (1996) · Nature · doi:10.1038/380252a0 · Cited by 955
Cited by
Sorted by citations
Items 101–169 of 169
Poutiainen, P., Jaronen, M., Quintana, F. J., & Brownell, A. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00085 · Cited by 33
WONOEP appraisal: Imaging biomarkers in epilepsy
van Vliet, E. A., Dedeurwaerdere, S., Cole, A. J., Friedman, A., Koepp, M. J., Potschka, H., Immonen, R. J., Pitkänen, A., & Federico, P. (2016) · Epilepsia · doi:10.1111/epi.13621 · Cited by 30
Tanimoto, Y., Yamasaki, T., Nagoshi, N., Nishiyama, Y., Nori, S., Nishimura, S., Iida, T., Ozaki, M., Tsuji, O., Ji, B., et al. (2020) · Stem Cells Translational Medicine · doi:10.1002/sctm.19-0150 · Cited by 31
Self-citationMiyoshi, M., Ito, H., Arakawa, R., Takahashi, H., Takano, H., Higuchi, M., Okumura, M., Otsuka, T., Kodaka, F., Sekine, M., et al. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.062554 · Cited by 30
Self-citationAssessment of radioligands for PET imaging of cyclooxygenase-2 in an ischemic neuronal injury model
Ji, B., Kumata, K., Onoe, H., Kaneko, H., Zhang, M., Seki, C., Ono, M., Shukuri, M., Tokunaga, M., Minamihisamatsu, T., et al. (2013) · Brain Research · doi:10.1016/j.brainres.2013.08.026 · Cited by 29
Self-citationVicente-Rodríguez, M., Singh, N., Turkheimer, F., Peris-Yague, A., Randall, K., Veronese, M., Simmons, C., Karim Haji-Dheere, A., Bordoloi, J., Sander, K., et al. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2021.05.025 · Cited by 28
Alzheimer’s Disease Genetics: Review of Novel Loci Associated with Disease
Tábuas‐Pereira, M., Santana, I. J., Guerreiro, R. J., & Brás, J. (2020) · Current Genetic Medicine Reports · doi:10.1007/s40142-020-00182-y · Cited by 26
Translocator protein and new targets for neuroinflammation
Herrera-Rivero, M., Heneka, M. T., & Papadopoulos, V. (2015) · Clinical and Translational Imaging · doi:10.1007/s40336-015-0151-x · Cited by 28
Ji, B., Ono, M., Yamasaki, T., Fujinaga, M., Zhang, M., Seki, C., Aoki, I., Kito, S., Sawada, M., Suhara, T., et al. (2021) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x21992457 · Cited by 25
Self-citationThe involvement of the mitochondrial membrane in drug delivery
Huang, Y., Ji, W., Zhang, J., Huang, Z. H., Ding, A., Bai, H., Peng, B., Huang, K., Du, W., Zhao, T., et al. (2024) · Acta Biomaterialia · doi:10.1016/j.actbio.2024.01.027 · Cited by 24
Hermes, D. J., Jacobs, I. R., Key, M. C., League, A. F., Yadav-Samudrala, B. J., Xu, C., McLane, V. D., Nass, S. R., Jiang, W., Meeker, R. B., et al. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01971-6 · Cited by 25
Liu, X., Li, W., Dai, L., Zhang, T., Xia, W., Liu, H., Ma, K., Xu, J., & Jin, Y. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.02.017 · Cited by 24
Nasal vaccine delivery attenuates brain pathology and cognitive impairment in tauopathy model mice
Takeuchi, H., Imamura, K., Ji, B., Tsukita, K., Enami, T., Takao, K., Miyakawa, T., Hasegawa, M., Sahara, N., Iwata, N., et al. (2020) · npj Vaccines · doi:10.1038/s41541-020-0172-y · Cited by 22
Self-citationYamasaki, T., Hatori, A., Zhang, Y., Mori, W., Kurihara, Y., Ogawa, M., Wakizaka, H., Rong, J., Wang, L., Liang, S. H., et al. (2021) · Theranostics · doi:10.7150/thno.64320 · Cited by 21
Self-citationKaneko, K., Irie, S., Mawatari, A., Igesaka, A., Hu, D., Nakaoka, T., Hayashinaka, E., Wada, Y., Doi, H., Watanabe, Y., et al. (2022) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-022-05719-7 · Cited by 20
The translocator protein as a drug target in Alzheimer’s disease
Chua, S. W., Kassiou, M., & Ittner, L. M. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.896201 · Cited by 20
Higuchi, M., Maeda, J., Ji, B., Maruyama, M., Okauchi, T., Tokunaga, M., Ono, M., & Suhara, T. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.01.003 · Cited by 20
Self-citationNeuroinflammation in Alzheimer’s disease: potential beneficial effects of vitamin D
Kouba, B. R., Camargo, A., & Rodrigues, A. L. S. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01188-5 · Cited by 22
Vicente-Rodríguez, M., Mancuso, R., Peris-Yague, A., Simmons, C., NIMA Consortium, Wlazly, D., Dickinson, A., Foster, A., Knight, C., Leckey, C., et al. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02769-y · Cited by 17
Imaging neuroinflammation in Alzheimer’s and other dementias: recent advances and future directions
Brooks, D. J. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.01.049 · Cited by 17
Ji, B., Chen, C.-J., Bando, K., Ashino, H., Shiraishi, H., Sano, H., Kasahara, H., Minamizawa, T., YAMADA, K., Ono, M., et al. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13293 · Cited by 17
Self-citationSigma-2 receptor binding is decreased in female, but not male, APP/PS1 mice
Sahlholm, K., Liao, F., Holtzman, D. M., Xu, J., & Mach, R. H. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.03.052 · Cited by 18
Xie, L., Yamasaki, T., Ichimaru, N., Yui, J., Kawamura, K., Kumata, K., Hatori, A., Nonomura, N., Zhang, M., Li, X., et al. (2011) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-011-9322-3 · Cited by 20
Self-citationLopez‐Picon, F. R., Keller, T., Bocancea, D. I., Helin, J. S., Krzyczmonik, A., Helin, S., Damont, A., Dollé, F., Rinne, J. O., Haaparanta‐Solin, M., et al. (2021) · Molecular Imaging and Biology · doi:10.1007/s11307-021-01646-5 · Cited by 16
Positron Emission Tomography in Animal Models of Tauopathies
Cao, L., Kong, Y., Ji, B., Ren, Y., Guan, Y., & Ni, R. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.761913 · Cited by 14
Self-citationTreating inflammation in childhood neurodegenerative disorders
Lim, M. J. (2011) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2010.03902.x · Cited by 16
Yamasaki, T., Kumata, K., Yanamoto, K., Hatori, A., Takei, M., Nakamura, Y., Koike, S., Andō, K., Suzuki, K., & Zhang, M. (2009) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2009.05.002 · Cited by 16
Self-citationA Protective Role of Translocator Protein in Alzheimer’s Disease Brain
Jung, M. E. (2020) · Current Alzheimer Research · doi:10.2174/1567205017666200217105950 · Cited by 17
Allopregnanolone and its antagonist modulate neuroinflammation and neurological impairment
Bäckström, T. C., Doverskog, M., Blackburn, T. P., Scharschmidt, B. F., & Felipo, V. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105668 · Cited by 14
Chronic benzodiazepine suppresses translocator protein and elevates amyloid β in mice
Tan, S., Metzger, D. B., & Jung, M. E. (2018) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2018.07.005 · Cited by 14
Towards molecular imaging of multiple sclerosis
Owen, D. R., Piccini, P. P., & Matthews, P. M. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458510390070 · Cited by 11
Basic Science of PET Imaging for Inflammatory Diseases
Kubota, K., Ogawa, M., Ji, B., Watabe, T., Zhang, M., Suzuki, H., Sawada, M., Nishi, K., & Kudo, T. (2019) · Springer eBooks · doi:10.1007/978-981-15-0810-3_1 · Cited by 12
Self-citationYamasaki, T., Fujinaga, M., Mori, W., Zhang, Y., Wakizaka, H., Nengaki, N., Xie, L., Hatori, A., & Zhang, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-15015-2 · Cited by 10
Self-citationTSPO: an emerging role in appetite for a therapeutically promising biomarker
Wang, J., & Beecher, K. (2021) · Open Biology · doi:10.1098/rsob.210173 · Cited by 10
In vivo imaging of neuroinflammation in Alzheimer's disease
Higuchi, M., Ji, B., Maeda, J., Sahara, N., & Suhara, T. (2016) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12308 · Cited by 8
Self-citationLuo, R., Wang, L., Ye, F., Wang, Y.-R., Fang, W., Zhang, M., & Wang, F. (2021) · Annals of Nuclear Medicine · doi:10.1007/s12149-021-01630-7 · Cited by 8
Self-citationTranslocator protein mediates olfactory repulsion
Ma, Z., Guo, X., & Liu, J. (2019) · The FASEB Journal · doi:10.1096/fj.201900528rr · Cited by 6
Pike, C., Kim, M., Schnitzer, K., Mercaldo, N. D., Edwards, R. R., Napadow, V., Zhang, Y., Morrissey, E. J., Alshelh, Z., Evins, A. E., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-063613 · Cited by 7
Comparative Assessment of TSPO Modulators on Electroencephalogram Activity and Exploratory Behavior
Hines, R. M., Aquino, E. A., Khumnark, M., Dávila, M. P., & Hines, D. J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.750554 · Cited by 6
Takuwa, H., Orihara, A., Takado, Y., Urushihata, T., Shimojo, M., Ishikawa, A., Takahashi, M., Barron, A. M., Ono, M., Maeda, J., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.11.04.368977 · Cited by 6
Self-citationPeng, Y., Zhang, Y., Wang, W., Liu, B., Zhang, Z., Gong, Z., Zhang, X., Xia, Y., You, X., & Wu, J. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176861 · Cited by 5
Leng, F., Hinz, R., Gentleman, S., Dani, M., Brooks, D. J., & Edison, P. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-230442 · Cited by 5
Characteristics of TSPO expression in marmoset EAE
Falk, I., Maric, D., Leibovitch, E., Sati, P., Lefeuvre, J., Luciano, N. J., Guy, J., Ha, S.-K., Owen, D. R., Aigbirhio, F., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03343-4 · Cited by 5
PET Applications in Animal Models of Neurodegenerative and Neuroinflammatory Disorders
Higuchi, M., Maeda, J., Ji, B., Tokunaga, M., Zhang, M., Maruyama, M., Ono, M., Fukumura, T., & Suhara, T. (2011) · Current topics in behavioral neurosciences · doi:10.1007/7854_2011_167 · Cited by 5
Self-citationRui, X., Ding, Y., Zhang, N., Zhao, X., Seki, C., Yamasaki, T., Fujinaga, M., Zhang, M.-R., Qian, J., Ji, B., et al. (2025) · EJNMMI Radiopharmacy and Chemistry · doi:10.1186/s41181-025-00345-8 · Cited by 4
Self-citationIs the Voltage-Dependent Anion Channel a Major Player in Neurodegenerative Diseases?
Neumann, S., & Heumann, R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136138 · Cited by 5
Lacivita, E., Stama, M. L., Maeda, J., Fujinaga, M., Hatori, A., Zhang, M., Colabufo, N. A., Perrone, R., Higuchi, M., Suhara, T., et al. (2016) · Chemistry & Biodiversity · doi:10.1002/cbdv.201500281 · Cited by 4
Self-citationGlial Modulation in Pain States: Translation into Humans
Horvath, R. J., Romero-Sandoval, E. A., & Leo, J. A. D. (2010) · Europe PMC (PubMed Central) · Cited by 3
Bartolo, N. D., Mortimer, N., Manter, M. A., Sanchez, N., Riley, M. M., O’Malley, T. T., & Hooker, J. M. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00607 · Cited by 3
Vitamin D in Alzheimer's disease: Neuroinflammatory, metabolic, and clinical implications
Kashif, M., Ho, M.-H., Pandurangan, A. K., Waseem, M., Majumder, D., & Chou, S. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261460850 · Cited by 4
Aertker, B. M., Kumar, A., Cardenas, F., Gudenkauf, F. J., Sequeira, D. J., Prossin, A. R., Srivastava, A. K., Cox, C. S., & Bedi, S. S. (2021) · ASN NEURO · doi:10.1177/17590914211014135 · Cited by 2
Lin, L. Y., Xu, S., & Wang, Q. (2012) · PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS · doi:10.3724/sp.j.1206.2012.00134 · Cited by 2
Schober, M. E., Requena, D. F., Ohde, J. W., Maves, S., & Pauly, J. R. (2021) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000003084 · Cited by 3
Ni, R. (2015) · Figshare · Cited by 2
TSPO’nun (18 kDa Translokatör Protein) Yapısı, İşlevi ve Patolojik Süreçlerdeki Rolü
Elma, Y., & Can, E. Y. (2024) · Medical Journal of Western Black Sea · doi:10.29058/mjwbs.1477979 · Cited by 1
Yamasaki, T., Zhang, Y., Mori, W., Kumata, K., Wakizaka, H., Arashi, D., Kurihara, Y., Ogawa, M., Nengaki, N., Fujinaga, M., et al. (2025) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2025.109579 · Cited by 1
Self-citationNotter, T., & Meyer, U. (2018) · Molecular Imaging and Biology · doi:10.1007/s11307-018-1172-4 · Cited by 1
Kaddour, H., Hamdi, Y., Vaudry, D., Leprince, J., Vaudry, H., Tonon, M., Amri, M., & Masmoudi‐Kouki, O. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/266379 · Cited by 1
In Vivo Imaging of Neuroinflammation in Acute Brain Injury
Thiel, A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8915-3_13
The translocator protein as a drug target in Alzheimer's
Chua, S. W., Kassiou, M., & Ittner, L. M. (2014)
Niu, M., & Syapin, P. J. (2013) · Berkeley Scientific Journal · doi:10.5070/bs3162016110
In-vivo imaging for pursuing molecular cascades in the pathogenesis of neurodegenerative diseases
Higuchi, M. (2009) · Rinsho Shinkeigaku · doi:10.5692/clinicalneurol.49.929
Self-citationGröhn, O. H. J., Deleye, S., Bertoglio, D., & Dedeurwaerdere, S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804066-9.00014-6
Central Nervous System Molecular Imaging
Sólnes, L. B., Jacobs, A. H., Coughlin, J. M., Du, Y., Goel, R., Hammoud, D. A., & Pomper, M. G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-816386-3.00088-0
Therapeutic and immunomodulatory functions of the translocator protein in Alzheimer's disease
Fairley, L. H. (2022) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/160865
Reilly, J. (2023) · Queensland University of Technology · doi:10.5204/thesis.eprints.242770
Wang, J., Qin, J., Kumata, K., Zhang, M.-R., Qian, J., Zhou, W. Y., & Ji, B. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1671065
Self-citationFairley, L. H., Sahara, N., Aoki, I., Ji, B., Suhara, T., Higuchi, M., & Barron, A. M. (2021) · Figshare · doi:10.6084/m9.figshare.14252304
Self-citationVicente‐Rodríguez, M., Mancuso, R., Peris-Yague, A., Simmons, C., Gómez‐Nicola, D., Perry, V. H., Turkheimer, F., Lovestone, S., Parker, C. A., & Cash, D. (2024) · Figshare · doi:10.6084/m9.figshare.26581280
Metadata
- Authors
- Ji, B., Maeda, J., Sawada, M., Ono, M., Okauchi, T., Inaji, M., Zhang, M.-R., Suzuki, K., Ando, K., Staufenbiel, M., Trojanowski, J. Q., Lee, V. M. Y., Higuchi, M., & Suhara, T.
- Affiliations
- National Institute of Radiological Sciences (JP)
- Research Institute of Environmental Medicine, Nagoya University (JP)
- Central Institute for Experimental Animals (JP)
- Novartis (Switzerland) (CH)
- University of Pennsylvania (US)
- Corresponding author
- Higuchi, Makoto
- ORCID
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2008-11-19
- Volume
- 28
- Issue
- 47
- Pages
- 12255-12267
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC2755188
- OpenAlex
- W2030029215
- Cited by
- 169
- References
- 71
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 6 · 2023: 5 · 2022: 7 · 2021: 16 · 2020: 13 · 2019: 4 · 2018: 10 · 2017: 12 · 2016: 14 · 2015: 14 · 2014: 12 · 2013: 9 · 2012: 10
- FWCI
- 7.02
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Institutional Repositories DataBase (IRDB) (submittedVersion, cc-by-nc-nd)
- QST-Repository (National Institutes for Quantum and Radiological Science and Technology) (submittedVersion)
- Funders
- Japan Society for the Promotion of Science (20023036)
- National Institute on Aging (P30AG010124)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- translocator protein (TSPO), Alzheimer's disease, glial activation, astrocyte activation, microglial activation, amyloid plaques, tau pathology, neurodegeneration, glial cell line-derived neurotrophic factor, neurotrophic support, neuroinflammation, neuroimaging biomarkers, mouse model
- MeSH terms
- Acetamides, Alzheimer Disease, Analysis of Variance, Animals, Cell Line, Transformed, Central Nervous System, Disease Models, Animal, Gene Expression Regulation, Glial Fibrillary Acidic Protein, Kainic Acid, Male, Mice, Inbred C57BL, Mice, Transgenic, Phenyl Ethers, Receptors, GABA-A, Amyloid beta-Protein Precursor, Oxidopamine, tau Proteins, Microglia, Cell Transplantation, Radiopharmaceuticals, Neurotoxicity Syndromes, Positron-Emission Tomography, Glial Cell Line-Derived Neurotrophic Factor, Mice, Rats, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
